Cellular retinol binding protein 1 could be a tumor suppressor gene in cervical cancer

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 9, 2013, Pages 1817-1825

  Mendoza Rodriguez, Mónica ^a,b,d   Arreola, Hugo ^a,d   Valdivia, Alejandra ^a   Peralta, Raúl ^a   Serna, Humberto ^c   Villegas, Vanessa ^a   Romero, Pablo ^a   Alvarado Hernández, Beatriz ^b   Paniagua, Lucero ^a   Marrero Rodríguez, Daniel ^a   Meraz, Marco A ^b   Salcedo, Mauricio ^a  

^a UMAE Hospital de Oncología CMN SXXI   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c HOSPITAL GENERAL DE MÉXICO   (Mexico)

^d INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Cervical cancer; Copy number; CRBP1; Expression; Suppressor gene

Indexed keywords

CELLULAR RETINOL BINDING PROTEIN; RBP1 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CASE CONTROL STUDY; COPY NUMBER; COPY NUMBER VARIATION; CRBP1; DNA METHYLATION; EXPRESSION; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HELA CELL; HUMAN; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; SUPPRESSOR GENE; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; UTERINE CERVIX TUMOR;

CERVICAL CANCER; COPY NUMBER; CRBP1; EXPRESSION; SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HELA CELLS; HUMANS; MIDDLE AGED; PHENOTYPE; PROMOTER REGIONS, GENETIC; RETINOL-BINDING PROTEINS, CELLULAR; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84885353748     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. Wani K, Huilgol N, Hongyo T, Shah K, Chatterjee N, Nair CK, Nomura T. Genetic alterations in the coding region of the bak gene in uterine cervical carcinoma. Br J Cancer 2003; 88: 1584-1586.
3. Mitra A, Murty V, Li R, Pratap M, Luthra UK, Chaganti RS. Allelotype analysis of cervical carcinoma. Cancer Res 1994; 54: 4481-4487.
4. Kloth J, Oosting J, Wezel T, Szuhai K, Knijnenburg J, Gorter A, Kenter GG, Fleuren GJ, Jordanova ES. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer. BMC Genomics 2007; 8: 1-13.
5. Hayslip J, Montero A. Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review. Mol Cancer 2006; 5: 44 1-7.
6. Bonazzi VF, Irwin D, Hayward NK. Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma. Genes Chromosome Cancer 2009; 48: 10-21.
7. Rothhammer T, Bosserhoff AK. Epigenetic events in malignant melanoma. Pigment Cell Res 2007; 20: 92-111.
8. Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A 1996; 93: 479-484.
9. Ried T, Heselmeyer-Haddad K, Blegen H, Schröck E, Auer G. Genomic changes defining genesis, progression and malignancy potential in human solid tumors: a phenotype/genotype correlation Gene Chromosome. Cancer 1999; 25: 195-204.
10. Dellas A, Torhorst J, Jiang F, Proffitt J, Schultheiss E, Holzgreve W, Sauter G, Mihatsch MJ, Moch H. Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical Stage IB detected by comparative genomic hybridization. Cancer Res 1999; 59: 3475-3479.
11. Kirchhoff M, Rose H, Petersen B, Maahr J, Gerdes T, Lundsteen C, Bryndorf T, Kryger-Baggesen N, Christensen L, Engelholm SA, Philip J. Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma Gene Chromosome. Cancer 1999; 24: 144-150.
12. Allen D, White D, Hutchins A, Scurry JP, Tabrizi SN, Garland SM, Armes JE. Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer 2000; 83: 1659-1663.
13. Oh EK, Kim YW, Kim IW, Liu HB, Lee KH, Chun HJ, Park DC, Oh EJ, Lee AW, Bae SM, Ahn WS. Differential DNA copy number aberrations in the progression of cervical lesions to invasive cervical carcinoma. Int J Oncol 2012; 41: 2038-46.
14. Rao PH, Arias-Pulido H, Lu XY, Harris CP, Vargas H, Zhang FF, Narayan G, Schneider A, Terry MB, Murty VV. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer 2004; 4: 5.
15. Hidalgo A, Baudis M, Petersen I, Arreola H, Piña P, Vázquez-Ortiz G, Hernández D, González J, Lazos M, López R, Pérez C, García J, Vázquez K, Alatorre B, Salcedo M. Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma. BMC Cancer 2005; 5: 77.
16. Kuppumbatti Y, Rexer S, Nakajo K, Nakaya K, Mira-y-Lopez R. CRBP suppresses breast can cer cell survival and anchorage-independent growth. Oncogene 2001; 20: 7413-7419.
17. Ross S, McCaffery P, Drager U, De Luca LM. Retinoids in embryonal development. Physiol Rev 2001; 80: 1021-1054.
18. Altucci L, Gronemeyer H. Nuclear receptors in cell life and death Trends Endocrinol. Metab 2001; 12: 460-468.
19. Ghyselinck B, Bavik C, Sapin V, Mark M, Bonnier D, Hindelang C, Dierich A, Nilsson CB, Håkansson H, Sauvant P, Azaïs-Braesco V, Frasson M, Picaud S, Chambon P. Cellular retinol-binding protein I is essential for vitamin A homeostasis. EMBO J 1999; 18: 4903-4914.
20. Kuppumbatti Y, Bleiweiss I, Mandeli J, Waxman S, Mira-Y-Lopez R. Cellular retinol-binding protein expression and breast cancer. J Natl Cancer Inst 2000; 92: 475-480.
21. Cvetkovic D, Williams S, Hamilton T. Loss of cellular retinol binding protein 1 gene expression in microdissected human ovarian cancer Clin. Cancer Res 2003; 9: 1013-1020.
22. Kwong J, Lo K, Chow L, To KF, Choy KW, Chan FL, Mok SC, Huang DP. Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma. Neoplasia 2005; 7: 67-74.
23. Peralta R, Baudis M, Vazquez G, Juárez S, Ortiz R, Decanini H, Hernandez D, Gallegos F, Valdivia A, Piña P, Salcedo M. Increased expression of cellular retinol- binding protein 1 in laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol 2010; 136: 931-938.
24. Peralta R, Valdivia A, Alvarado-Cabrero I, Gallegos F, Apresa T, Hernández D, Mendoza M, Romero P, Paniagua L, Ibáñez M, Cabrera L, Salcedo M. Correlation between expression of cellular retinol-binding protein 1 and its methylation status in larynx cancer. J Clin Pathol 2011; 65: 46-50.
25. Caceres-Cortes J, Alvarado J, Waga K, Rangel-Corona R, Monroy-Garcia A, Rocha-Zavaleta L, Urdiales-Ramos J, Weiss-Steider B, Haman A, Hugo P, Brousseau R, Hoang T. Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias. Cancer Res 2001; 61; 6281-6289.
26. Livak K, Schmittgen T. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Methods. Methods 2001; 25: 402-408.
27. Herman J, Graff J, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93: 9821-9826.
28. Esteller M, Guo M, Moreno V, Peinado MA, Capella G, Galm O, Baylin SB, Herman JG. Hypermethylation-associated inactivation of the cellular retinol-binding protein 1 gene in human cancer. Cancer Res 2002; 62: 5902-5905.
29. Valdivia A, Peralta R, Matute-González M, García Cebada JM, Casasola I, Jiménez-Medrano C, Aguado-Pérez R, Villegas V, González-Bonilla C, Manuel-Apolinar L, Ibáñez M, Salcedo M. Co-expression of metalloproteinases 11 and 12 in cervical scrapes cells from cervical precursor lesions. Int J Clin Exp Pathol 2011; 4: 674-82.
30. Farias E, Ong D, Ghyselinck N, Nakajo S, Kuppumbatti YS, Mira y Lopez R. Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity. J Natl Cancer Inst 2005; 97: 21-29.
31. Jeronimo C, Henrique R, Oliveira J, Lobo F, Pais I, Teixeira MR, Lopes C. Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer. J Clin Pathol 2004; 57: 872-876.
32. Hildesheim A, Schiffman M, Gravitt P, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994; 169: 235-240.
33. zur Hausen H. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet 1994; 343: 955-957.